
US Oncology Launch Lead — Mevrometostat Strategy
Scorpion Therapeutics, Phila, Pennsylvania, United States
A leading biopharmaceutical company is seeking a strategic leader to direct the US launch of Mevrometostat. The role entails developing the US go-to-market strategy, executing launch frameworks, engaging with stakeholders, and managing vendor relationships to optimize launch performance. Ideal candidates will have substantial pharmaceutical experience, particularly in Oncology marketing, and a proven track record in successful product launches. Strong analytical, communication, and leadership skills are essential for this position.
#J-18808-Ljbffr